{
    "organizations": [],
    "uuid": "a2ceb6a3892645616188896b7b5a66b27a4b198d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-indivior-says-filed-nds-with-healt/brief-indivior-says-filed-nds-with-health-canadas-for-sublocade-injection-idUSFWN1RX0O3",
    "ord_in_thread": 0,
    "title": "BRIEF-Indivior Says Filed NDS With Health Canada's For Sublocade Injection",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20, 2018 / 1:08 PM / Updated 5 minutes ago BRIEF-Indivior Says Filed NDS With Health Canada's For Sublocade Injection Reuters Staff 1 Min Read \nApril 20 (Reuters) - Indivior PLC: \n* FILED A NEW DRUG SUBMISSION (NDS) WITH HEALTH CANADAâ€™S THERAPEUTIC DRUGS DIRECTORATE FOR SUBLOCADE INJECTION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-04-20T16:05:00.000+03:00",
    "crawled": "2018-04-20T16:24:19.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "say",
        "filed",
        "nd",
        "health",
        "canada",
        "sublocade",
        "injection",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "indivior",
        "plc",
        "filed",
        "new",
        "drug",
        "submission",
        "nd",
        "health",
        "canada",
        "therapeutic",
        "drug",
        "directorate",
        "sublocade",
        "injection",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}